Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-04971729 (Ertugliflozin (PF-04971729)) is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 45.00 | |
10 mg | In stock | $ 63.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 148.00 | |
200 mg | In stock | $ 238.00 | |
500 mg | In stock | $ 392.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | PF-04971729 (Ertugliflozin (PF-04971729)) is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2). |
Targets&IC50 | SGLT2 (human):0.877 nM |
Synonyms | MK-8835, PF-04971729 |
Molecular Weight | 436.88 |
Formula | C22H25ClO7 |
CAS No. | 1210344-57-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 46 mg/mL (105.29 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ertugliflozin 1210344-57-2 GPCR/G Protein SGLT MK8835 inhibit MK-8835 MK 8835 Inhibitor PF04971729 PF 04971729 Sodium-dependent glucose cotransporters PF-04971729 inhibitor